TR201009168A2 - Water dispersible cefpodoxime proxetil formulations. - Google Patents

Water dispersible cefpodoxime proxetil formulations.

Info

Publication number
TR201009168A2
TR201009168A2 TR2010/09168A TR201009168A TR201009168A2 TR 201009168 A2 TR201009168 A2 TR 201009168A2 TR 2010/09168 A TR2010/09168 A TR 2010/09168A TR 201009168 A TR201009168 A TR 201009168A TR 201009168 A2 TR201009168 A2 TR 201009168A2
Authority
TR
Turkey
Prior art keywords
formulations
water dispersible
cefpodoxime proxetil
proxetil
cefpodoxime
Prior art date
Application number
TR2010/09168A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2010/09168A priority Critical patent/TR201009168A2/en
Priority to PCT/TR2011/000255 priority patent/WO2012060790A2/en
Priority to PCT/TR2011/000251 priority patent/WO2012060786A2/en
Publication of TR201009168A2 publication Critical patent/TR201009168A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, sefpodoksim proksetil içeren farmasötik formulasyonlara ilişkindir.The present invention relates to pharmaceutical formulations containing cefpodoxime proxetil.

TR2010/09168A 2010-11-05 2010-11-05 Water dispersible cefpodoxime proxetil formulations. TR201009168A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2010/09168A TR201009168A2 (en) 2010-11-05 2010-11-05 Water dispersible cefpodoxime proxetil formulations.
PCT/TR2011/000255 WO2012060790A2 (en) 2010-11-05 2011-11-03 Water dispersible cefpodoxime proxetil formulations
PCT/TR2011/000251 WO2012060786A2 (en) 2010-11-05 2011-11-03 Cefpodoxime proxetil formulations comprising viscosity agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/09168A TR201009168A2 (en) 2010-11-05 2010-11-05 Water dispersible cefpodoxime proxetil formulations.

Publications (1)

Publication Number Publication Date
TR201009168A2 true TR201009168A2 (en) 2012-05-21

Family

ID=45446166

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/09168A TR201009168A2 (en) 2010-11-05 2010-11-05 Water dispersible cefpodoxime proxetil formulations.

Country Status (2)

Country Link
TR (1) TR201009168A2 (en)
WO (2) WO2012060786A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013151517A1 (en) * 2012-04-04 2013-10-10 Mahmut Bilgic Tablet formulations comprising cefpodoxime proxetil and clavulanic acid
CN103142506B (en) * 2013-04-03 2015-02-25 天津医药集团津康制药有限公司 Cefpodoxime proxetil granules and preparation method thereof
CN103230367B (en) * 2013-05-07 2014-11-12 山东罗欣药业集团股份有限公司 Cefpodoxime proxetil composition dry suspension and preparation method thereof
MX2017007287A (en) * 2014-12-01 2017-08-25 Sun Pharmaceutical Ind Ltd Extended-release cefpodoxime proxetil composition.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486425A (en) 1980-09-30 1984-12-04 Sankyo Company Limited 7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]-3-methoxymethyl-3-cephem-4-carboxylates
WO2002067943A1 (en) * 2001-02-27 2002-09-06 Ranbaxy Laboratories Limited Oral pharmaceutical composition of cefpodoxime proxetil
TW200404550A (en) * 2002-07-08 2004-04-01 Sankyo Co Cepharospolin formulation for oral use
JP4526247B2 (en) * 2002-07-08 2010-08-18 第一三共株式会社 Oral cephalosporins
KR20050062514A (en) * 2002-07-16 2005-06-23 랜박시 래보러터리스 리미티드 Dispersible tablets for oral administration
JP2008540403A (en) * 2005-05-05 2008-11-20 ルピン・リミテッド Stabilized oral pharmaceutical composition of cephalosporin
TR201002878A2 (en) * 2010-04-13 2011-10-21 Bi̇lgi̇ç Mahmut Pharmaceutical compositions comprising cefpodoxime proxetil.

Also Published As

Publication number Publication date
WO2012060790A2 (en) 2012-05-10
WO2012060786A3 (en) 2012-07-26
WO2012060786A2 (en) 2012-05-10
WO2012060790A3 (en) 2012-09-20

Similar Documents

Publication Publication Date Title
JOP20180102B1 (en) Pharmaceutical composition
IN2012DN06714A (en)
MX340831B (en) Pesticidal compositions.
BR112012029917A2 (en) uncoupled adjuvant nanotransport compositions
EA201390586A1 (en) CRISPR-CAS LACTOCOCCUS SEQUENCES
EA201270256A1 (en) DERIVATIVES OF T1-SUBSTITUTED 5-FLUOR-2-OXOPYRIMIDINON-1 (2H) -KARBOXAMID
CL2014000815A1 (en) Compounds derived from insecticidal 2-methoxybenzamides; insecticidal compositions
EA201300733A1 (en) RECOMBINANT MICOBACTERIA AS A VACCINE
IT1398957B1 (en) GAS CLEANING SYSTEM PRODUCED BY GASIFICATORS.
TR201009168A2 (en) Water dispersible cefpodoxime proxetil formulations.
WO2011029536A3 (en) Use of cyclic keto-enols for combating plant pathogenic bacteria
CO6761388A2 (en) Pharmaceutical compositions comprising alisporivir
TR201007106A1 (en) Cefpodoxime proxetil formulations.
TR201002878A2 (en) Pharmaceutical compositions comprising cefpodoxime proxetil.
IT1400666B1 (en) PROCEDURE FOR THE SYNTHESIS OF 5-AMINO, 1-FENYL, 3-CYAN, 4-TRIFLUOROMETIL SULFINIL PIRAZOLI.
WO2012004073A3 (en) Use of beta-isophorone as solvent
EA201300607A1 (en) IONIC LIQUID ROTIGOTINE
IT1406067B1 (en) EUDERMIC COMPOSITIONS.
TR201007107A1 (en) Formulations of cefpodoxime proxetil containing taste regulating agent.
IN2014DN05954A (en)
UA42144U (en) Use of iodide s,s-diisopropyl-n-(1-methyl-3- pyridoyl)sulfimine as inducer of phosphorus accumulation by plants
UA42812U (en) Use of thiotriazolin ointment as an agent, having photoprotective properties
FI20100329A0 (en) Immunomodulatory adjuvant therapy
IT1399582B1 (en) OUT-LIFT STABILIZATION SYSTEM.
ITRM20110583A1 (en) FORMULATIONS.